换一批
第一作者：
Yuankai,Shi
第一单位：
Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. syuankai@cicams.ac.cn.
作者：
Yuankai,Shi [1]
;
Jian,Fang [2]
;
Ligang,Xing [3]
;
Yu,Yao [4]
;
Jian,Zhang [5]
;
Lian,Liu [6]
;
Yongsheng,Wang [7]
;
Changlu,Hu [8]
;
Jianping,Xiong [9]
;
Zhihua,Liu [10]
;
Runxiang,Yang [11]
;
Zhen,Wang [12]
;
Enfeng,Zhao [13]
;
Mengzhao,Wang [14]
;
Yanqiu,Zhao [15]
;
Kejing,Tang [16]
;
Zhihua,Li [17]
;
Zhengbo,Song [18]
;
Yongsheng,Li [19]
;
Wu,Zhuang [20]
;
Bo,Jin [21]
;
Ying,Cheng [22]
;
Yanping,Hu [23]
;
Yanhong,Gu [24]
;
Lin,Wu [25]
;
Rui,Ma [26]
;
Qitao,Yu [27]
;
Yan,Yu [28]
;
Jun,Zhao [2]
;
Hui,Zhao [29]
;
Dongqing,Lv [30]
;
Yanhong,Shang [31]
;
Puyuan,Xing [32]
;
Jin,Zhou [33]
;
Xingya,Li [34]
;
Zhe,Liu [35]
;
Zhaoxia,Dai [36]
;
Guohao,Xia [37]
;
Xueqin,Chen [38]
;
Yi,Ba [39]
;
Chunmei,Bai [14]
;
Qingshan,Li [40]
;
Guangyu,An [41]
;
Weiguo,Hu [42]
;
Yinxiang,Wang [43]
;
Andrea,Wang-Gillam [44]
;
Yuli,Ding [43]
;
Qiao,Li [43]
;
Zhiyue,Rao [43]
作者单位：
Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. syuankai@cicams.ac.cn.
[1]
Beijing Cancer Hospital, Beijing, China.
[2]
Shandong Cancer Hospital, Jinan, China.
[3]
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
[4]
Fudan University Shanghai Cancer Center, Shanghai, China.
[5]
Qilu Hospital of Shandong University, Jinan, China.
[6]
West China Hospital of Sichuan University, Chengdu, China.
[7]
Anhui Provincial Cancer Hospital, Hefei, China.
[8]
The First Affiliated Hospital of Nanchang University, Nanchang, China.
[9]
Jiangxi Cancer Hospital, Nanchang, China.
[10]
Yunnan Cancer Hospital, Kunming, China.
[11]
Linyi Cancer Hospital, Linyi, China.
[12]
Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine of Hebei Province, Cangzhou, China.
[13]
Peking Union Medical College Hospital, Beijing, China.
[14]
Henan Cancer Hospital, Zhengzhou, China.
[15]
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
[16]
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
[17]
Zhejiang Cancer Hospital, Hangzhou, China.
[18]
Chongqing Cancer Hospital, Chongqing, China.
[19]
Fujian Cancer Hospital, Fuzhou, China.
[20]
The First Affiliated Hospital of China Medical University, Shenyang, China.
[21]
Jilin Cancer Hospital, Changchun, China.
[22]
Hubei Cancer Hospital, Wuhan, China.
[23]
Jiangsu Province Hospital, Nanjing, China.
[24]
Hunan Cancer Hospital, Changsha, China.
[25]
Liaoning Cancer Hospital & Institute, Shenyang, China.
[26]
Guangxi Medical University Cancer Hospital, Nanning, China.
[27]
Harbin Medical University Cancer Hospital, Harbin, China.
[28]
The Second Hospital of Anhui Medical University, Hefei, China.
[29]
Taizhou Hospital of Zhejiang Province, Taizhou, China.
[30]
Affiliated Hospital of Hebei University, Baoding, China.
[31]
Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
[32]
Sichuan Cancer Hospital, Chengdu, China.
[33]
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
[34]
Beijing Chest Hospital Affiliated to Capital Medical University, Beijing, China.
[35]
The Second Hospital of Dalian Medical University, Dalian, China.
[36]
Jiangsu Cancer Hospital, Nanjing, China.
[37]
Hangzhou Cancer Hospital, Hangzhou, China.
[38]
Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
[39]
Affiliated Hospital of Chengde Medical University, Chengde, China.
[40]
Affiliated Beijing Chaoyang Hospital of Capital Medical University, Beijing, China.
[41]
Renmin Hospital of Wuhan University, Wuhan, China.
[42]
Jacobio Pharmaceuticals Co., Ltd., Beijing, China.
[43]
Jacobio (US) Pharmaceuticals, Inc., Burlington, MA, USA.
[44]
医学主题词
人类(Humans);中年人(Middle Aged);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);原癌基因蛋白质类p21(ras)(Proto-Oncogene Proteins p21(ras));男(雄)性(Male);女(雌)性(Female);老年人(Aged);肺肿瘤(Lung Neoplasms);突变(Mutation);成年人(Adult);老年人, 80以上(Aged, 80 and over)
DOI
10.1038/s41591-024-03401-z
PMID
39762419
发布时间
2025-04-30
- 浏览0
Nature medicine
Nature medicine
894-900页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
